Off-label marketing can pose significant risks. It can lead to the widespread use of drugs without sufficient evidence of their safety and efficacy for the off-label indication. This can result in adverse effects, compromised patient safety, and ethical concerns. Additionally, it undermines the regulatory framework designed to ensure drug safety and efficacy.
